CIK 0001439222 · Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Planned sale Chief Legal Officer sold 3,280 shares at $34.71 ($113,849)
- 4 Planned sale Chief Medical Officer sold 2,940 shares at $34.71 ($102,047)
- 4 Planned sale Chief Financial Officer sold 3,141 shares at $34.71 ($109,024)
- 4 Planned sale Chief Commercial Officer sold 3,262 shares at $34.71 ($113,224)
- 4 Planned sale Chief Corp Dev & Strategy sold 2,959 shares at $34.71 ($102,707)
- 4 Planned sale Chief Executive Officer sold 19,068 shares at $34.71 ($661,850)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Planned sale Chief Corp Dev & Strategy sold 2,959 shares at $27.80 ($82,260)
- 144 Insider Sale of Securities
- 4 Open-market sale Principal Accounting Officer sold 5,272 shares at $28.88 ($152,255)
- 4 Planned sale Chief Executive Officer sold 18,055 shares at $28.96 ($522,873)
Page 3 of 66 · 1,304 filings